Jefferies Financial Group Inc. Purchases 41,300 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Jefferies Financial Group Inc. grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 98.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 83,100 shares of the company's stock after acquiring an additional 41,300 shares during the period. Jefferies Financial Group Inc. owned 0.07% of Henry Schein worth $5,751,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Mackenzie Financial Corp raised its position in Henry Schein by 97.2% in the fourth quarter. Mackenzie Financial Corp now owns 8,819 shares of the company's stock worth $610,000 after acquiring an additional 4,348 shares during the period. Forum Financial Management LP purchased a new stake in shares of Henry Schein in the fourth quarter worth $221,000. Toronto Dominion Bank increased its stake in shares of Henry Schein by 6.7% in the fourth quarter. Toronto Dominion Bank now owns 66,997 shares of the company's stock worth $4,636,000 after purchasing an additional 4,218 shares in the last quarter. GF Fund Management CO. LTD. purchased a new stake in shares of Henry Schein in the fourth quarter worth $194,000. Finally, Investment Management Corp VA ADV purchased a new stake in shares of Henry Schein in the fourth quarter worth $32,000. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of analyst reports. Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Barrington Research reduced their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Piper Sandler reduced their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Price Performance

HSIC traded down $2.12 during trading on Friday, hitting $69.86. 3,123,095 shares of the company traded hands, compared to its average volume of 1,674,677. The company has a market cap of $8.50 billion, a PE ratio of 28.75, a P/E/G ratio of 2.13 and a beta of 0.87. The stock's 50-day simple moving average is $67.65 and its two-hundred day simple moving average is $71.63. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the company posted $1.10 earnings per share. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.